My break even on this stock is still about $13/share, and the float is super tiny and the OS is the smallest I have seen in 10 years. Huge run up potential here. I have not seen the news yet. I have been in this stock since 2009. The stock had near zero volume for about 2 years, then a wee little bit of selling this year. It was trading around $2 in 2014. They have huge special loan reserve deal for about 10 Mil dollars they have not tapped in 2-3 years yet to fund acquisitions. They have bought 2 biotechs already. They have patents and early stage drug trials. CEO still owns about 70-80% of the OS!!!
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.